Haba Laboratories

Haba Laboratories Forward P/E

The Forward P/E Ratio of Haba Laboratories (4925.T) as of Oct 20, 2026 is 8.65. In the previous year, Forward P/E Ratio was 11.41 — a change of -24.17% (lower).

Forward P/E

8.65

YoY

-24.17%

Last updated:

Forward P/E Ratio of Haba Laboratories is 2026 8.65 . Forward P/E Ratio of Haba Laboratories was 2025 11.41 . It decreases by -24.17% lower compared to the previous year.

The Haba Laboratories Forward P/E history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Forward P/E
Date
Forward P/E
Jan 1, 2019
3.15 JPY
Jan 1, 2020
5.01 JPY
Jan 1, 2021
30.39 JPY
Jan 1, 2022
-24.44 JPY
Jan 1, 2023
-9.29 JPY
Jan 1, 2024
-3.10 JPY
Jan 1, 2025
11.41 JPY
Jan 1, 2026
8.65 JPY
The Haba Laboratories Forward P/E history
YEARForward P/EYoY
8.65-24.17%
11.41-467.46%
-3.10-66.59%
-9.29-61.99%
-24.44-180.44%
30.39+506.91%
5.01+59.00%
3.15-23.49%
4.12-24.05%
5.42-19.05%
6.69-95.44%
146.68+1,943.88%
7.18—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Haba Laboratories Stock analysis

What does Haba Laboratories do? HABA Laboratories, Inc. generates revenue through the development, manufacture, and sale of natural cosmetics, quasi-drugs, and nutritional supplements. The company distributes its products via wholesale to department stores and through mail order services to general customers, while also selling directly at its own retail stores. Its main business focuses on women's and men's cosmetics, targeting consumers seeking natural beauty and health solutions through both retail and direct channels. The firm's revenue streams include wholesale distribution to retailers and wholesalers, alongside direct sales at its retail stores. Products are marketed under the HABA brand, with a focus on natural ingredients for cosmetics, quasi-drugs, and nutritional supplements. The company serves both individual consumers through mail order and business clients through wholesale partnerships. HABA Laboratories' business model relies on a dual approach of B2B and B2C sales, with department stores, retailers, and wholesalers as key wholesale partners. The company's product portfolio caters to the growing demand for natural personal care items, leveraging its retail presence and mail order services to reach a broad customer base. Haba Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Haba Laboratories stock

Forward P/E Ratio of Haba Laboratories is 8.65 in 2026.

Forward P/E Ratio of Haba Laboratories changed from 11.41 to 8.65, representing a -24.17% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Forward P/E Ratio Haba Laboratories since 2006 – with annual values, charts, and detailed analysis.

The Forward P/E uses estimated future earnings to value a stock. A lower forward P/E relative to the trailing P/E suggests analysts expect earnings growth.

To evaluate Forward P/E Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Forward P/E Ratio.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Forward P/E Ratio's Haba Laboratories with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Haba Laboratories

All Key Metrics — Haba Laboratories